Managing Information as a Strategic Productivity AssetThis is an industry-sponsored event and is NOT a certified CME/CE activity. If you'd like to learn more about the pharmaceutical industry, then you may want to participate in this event.
Live Webcast: December 2, 2009 at 11:00 AM EST
Major changes are underway in the reporting and enforcement environment for drug safety, with new regulations now in place in the US and Europe that require sponsoring companies to provide timely, comprehensive and accurate information to authorities, virtually on demand. REMS, RMPs, RiskMAPS, the Sentinel Initiative and other FDA programs geared to identifying product safety risks before they emerge as public health challenges raise the bar on what the sponsors must do to comply.Key Learning Objectives:
These include making significant investments in upgrading the quality and scope of surveillance data to track the impact of a medicine’s use on the patient community at every stage of its life cycle, from clinical trials to post marketing surveillance – in the latter case, this can now include obligations to monitor safety and risk well beyond the time of patent expiry.
In this new regulatory environment, relevant information must be accessible for analysis and reporting to meet strict regulatory time frames. In addition, the method of sharing this information with external parties must have controls in place to ensure the confidentiality of what, for knowledge-based industries like pharmaceuticals, is a key strategic asset. Technology and customized resource platforms can make this process more efficient by standardizing document distribution on a global basis, and allowing the detailed analysis demanded in sensitive areas like adverse event reporting.
1. non clinical physician jobsNotice a pattern? Currently, visits from major search engines represent roughly 40% of the traffic to this website.
2. non clinical jobs for physicians
3. non clinical careers for physicians
4. non-clinical physician jobs
5. non clinical jobs
6. non-clinical careers for physicians
7. nonclinical physician jobs
8. nonclinical physician jobs, california
9. non medical jobs for physicians
10. non clinical jobs for doctors
1 Systems EngineerNotice how 3 out of the 10 are in the health care field? If you continue down the list, you'll also see Anesthesiologist (#11), Pharmacist (#13), Occupational Therapist (#14), Nurse Anesthetist (#15), Physician/General Practice (#19), Physician/Obstetrician/Gynecologist (#22), Clinical Psychologist (#23), Psychiatrist (#24), and the list just goes on...
2 Physician Assistant
3 College Professor
4 Nurse Practitioner
5 Information Technology Project Manager
6 Certified Public Accountant
7 Physical Therapist
8 Computer/Network Security Consultant
9 Intelligence Analyst
10 Sales Director
• The URL has changed to http://members.nonclinicaljobs.com (the old URL will still work, but it will forward to this new domain). You’ll see that this is now a subdomain on http://www.nonclinicaljobs.comThanks for participating in the forum. It’s great to hear people’s stories and to encourage each other as we all go through transitions in our lives. We’re always actively exploring consulting opportunities and other collaborative partnerships.
• We have reached over 1,000 members! I hope you will spread the word this holiday season as you interact with family and friends. If you know anyone who would be interested in non-clinical opportunities, please encourage them to join.
• Our Facebook fan page is growing. Have you become a fan? What are you waiting for?
• New tabs with links to social media/networking resources such as Twitter, LinkedIn, Facebook, and the main site: http://www.nonclinicaljobs.com
• Integrate real time contextual information into their workflowIf you ever attend HIMSS (Healthcare Information and Management Systems Society), you'll see Cisco Healthcare Solutions everywhere you go.
• Avoid spending $1 million on medical equipment
• Slashed telephony costs
• Wirelessly-network smart IV pumps to distribute drug dosage updates in real time
Park Hyatt PhiladelphiaEXHIBITING COMPANIES
Monday, November 16, 2009
11am to 4pm
• Medicare and Medicaid Clinical Compliance ManagementThe acronym "EHR" is widely used to refer to electronic health records, so don't get that confused with this company. Here's a bit of history regarding this EHR (from their website):
- Concurrent Admission Review and Certification (Inpatient vs. Observation Status)
- Surgical/Procedural Setting Review and Certification
• Medicare and Medicaid Denials Review & Appeal Management
- QIO, MAC/FI and RAC Denials Management
• Concurrent Commercial Payor Denials Management
• Retrospective Commercial Payor Denials Management
• Length of Stay Management
• ER Admissions & Transfer Center Mgmt.
Founded in 1997, EHR, The Physician Advisor Company™, is nationally recognized as the leading provider of real-time, point of care, expert Physician Medical Management Solutions that improve hospital revenue integrity and maintain the highest level of quality of care and regulatory compliance. EHR's expert physicians, the EHR Physician Advisors, provide hospitals and health systems with an outsourced operational, technological, and clinical resource to achieve the hospital’s goal of effectively managing clinical care while maintaining sound financial performance.They appear to be hiring for a Physician Advisor. What are the qualifications? M.D. or D.O. with 3+ years of post-residency inpatient clinical practice preferred. Medical licensure mandatory; Board Certification preferred. To learn more, visit: http://www.ehrdocs.com
We specialize in company creation and early-stage investment in novel therapeutics, medical devices, diagnostics, and research technologies. We focus on major unmet medical needs that have yet to be addressed by emerging science. Enlisting the world’s leading academic and industry experts, we identify novel technologies (often prior to publication) and create companies that drive those discoveries to commercially and clinically driven milestones. Once those milestones are achieved, we build out the leadership team, create syndicates for later stage financing rounds, and position the technology to make the broadest impact through public financing or acquisition.Going back to Pfizer now: Pfizer is splitting its R&D operations into a biotherapeutics division which will be headed by Mikael Dolsten and a pharmatherapeutics division which will be headed by Martin Mackay.
This webinar, provides participants with the opportunity to review current industry practices regards to the complexities of promotional review for online channels and other off-label risk areas on the internet, including discussion surrounding the latest social networking sites and other non-traditional media channels.Key Questions to Be Addressed:
• What happened at the recent FDA meeting and what if any hard information resultedThe Center for Business Intelligence has been reviewed and approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET).
• How much listening vs. monitoring and commenting should a company do of user-generated information/social media?
• What are the business reasons for engaging in social media?
• What are the pros and cons of being involved in user-generated content on balance to the risks for off-label discussion and adverse event reporting?
REMS, RMPs, RiskMAPS, the Sentinel Initiative and other FDA programs geared to identifying product safety risks before they emerge as public health challenges raise the bar on what the sponsors must do to comply. These include making significant investments in upgrading the quality and scope of surveillance data to track the impact of a medicine’s use on the patient community at every stage of its life cycle, from clinical trials to post marketing surveillance – in the latter case, this can now include obligations to monitor safety and risk well beyond the time of patent expiry.Key Learning Objectives :
In this new regulatory environment, relevant information must be accessible for analysis and reporting to meet strict regulatory time frames. In addition, the method of sharing this information with external parties must have controls in place to ensure the confidentiality of what, for knowledge-based industries like pharmaceuticals, is a key strategic asset. Technology such as configurable web-based exchange platforms can make this process more efficient by standardizing document distribution on a global basis, while adding a layer of control and reporting capabilities.
• Learn how an understanding of regulatory methodology can facilitate rapid responses to safety queriesSpeakers:
• Learn how web-based repositories and document distribution can facilitate access and submission of time-sensitive adverse event analyses and reports
• Understand how to quantify the time and money savings realized by moving your safety document distribution process online
Christopher Milne, PhD, DVMTo register for this event, click here.
Deputy Director and Lead Policy Advisor
Tufts University Center for the Study of Drug Development
Gail Farfel, PhD
GM Group Consulting
Senior Director, Drug Safety and Regulatory Affairs
Vice President, Product Marketing